Neupane Shankar, Berg Elizabeth
Pediatric Gastroenterology, New York City Health & Hospitals/Lincoln Medical Center, Bronx, USA.
Pediatric Gastroenterology, Columbia University, New York, USA.
Cureus. 2024 Nov 23;16(11):e74289. doi: 10.7759/cureus.74289. eCollection 2024 Nov.
We present the case of a previously healthy 11-year-old boy who developed hepatitis in the setting of regular intake of Apetamin. Apetamin is an appetite stimulant not approved by the United States Food and Drug Administration that contains cyproheptadine, lysine, and multiple B vitamins. It is illegally imported into the United States and can be purchased online. The patient was referred to the gastrointestinal clinic for evaluation of hepatitis based on screening laboratory testing collected during a routine healthcare visit. Laboratory workup revealed elevated transaminases six months after beginning Apetamin and positive anti-smooth muscle antibody. Liver enzymes improved following the discontinuation of Apetamin. The case highlights the potential of dietary supplements to cause hepatic injury and the importance of a thorough history of complementary alternative medication usage.
我们报告了一例先前健康的11岁男孩的病例,该男孩在经常服用Apetamin的情况下出现了肝炎。Apetamin是一种未经美国食品药品监督管理局批准的食欲刺激剂,含有赛庚啶、赖氨酸和多种B族维生素。它被非法进口到美国且可在网上购买。该患者因在常规医疗就诊期间进行的筛查实验室检测而被转诊至胃肠病诊所评估肝炎。实验室检查显示在开始服用Apetamin六个月后转氨酶升高且抗平滑肌抗体呈阳性。停用Apetamin后肝酶有所改善。该病例凸显了膳食补充剂导致肝损伤的可能性以及全面了解补充替代药物使用史的重要性。